Compare HRTX & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRTX | PMO |
|---|---|---|
| Founded | 1983 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.8M | 279.5M |
| IPO Year | 2007 | N/A |
| Metric | HRTX | PMO |
|---|---|---|
| Price | $0.94 | $10.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 61.6K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | ★ $154,904,000.00 | N/A |
| Revenue This Year | $15.28 | N/A |
| Revenue Next Year | $20.29 | N/A |
| P/E Ratio | ★ N/A | $24.90 |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $0.74 | $9.56 |
| 52 Week High | $2.61 | $10.87 |
| Indicator | HRTX | PMO |
|---|---|---|
| Relative Strength Index (RSI) | 56.47 | 54.77 |
| Support Level | $0.74 | $10.43 |
| Resistance Level | $1.41 | $10.52 |
| Average True Range (ATR) | 0.06 | 0.11 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 84.74 | 87.50 |
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.